- $74.15m
- $48.76m
- $6.02m
U.S. STOCKS ON THE MOVE-Vertex Pharma, Duluth, Molecular Templates
U.S. STOCKS ON THE MOVE-BJ's Wholesale, FuelCell Energy, Holley
Helius Medical rises on Canadian approval for stroke therapy
Brief: Helius Medical Announces Health Canada Authorization To Market Portable Neuromodulation Stimulator Device For Treatment Of Gait Deficit Due To Mild And Moderate Symptoms From Stroke
Helius Medical Technologies Inc expected to post a loss of 13 cents a share - Earnings Preview
Brief: Helius Medical Announces Preliminary Results For Q4, Full Year 2022
Brief: Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial Results
Brief: Helius Medical Technologies Reports Q2 2022 Results
U.S. STOCKS ON THE MOVE-Energy firms, Retail chatter, MoneyGram
U.S. STOCKS ON THE MOVE-Big banks, Beyond Meat, Cinemark
Brief: Helius Medical Technologies Inc Announces Pricing Of $18 Mlon Public Offering
Helius Medical dive on discounted equity offering
U.S. STOCKS ON THE MOVE-BioCryst, gold miners, ChemoCentryx
U.S. STOCKS ON THE MOVE-Global Blood, Alibaba.com, Albemarle
Brief: Helius Medical Technologies Files Prospectus Related To Offering Of Up To 14.56 Mln Shares, Warrants To Purchase Up To 14.56 Mln Shares
Brief: Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results And Provides Update On U.S. Commercial Launch Of Pons
Brief: Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions For Pons
Brief: Helius Medical Technologies Posts Q4 Loss Per Share $1.31
Brief: Helius Medical Technologies Sees Q4 Revenue Up More Than 30 Percent